Results 1 to 10 of about 51,273 (262)
Thyroid differentiation profile for differentiated thyroid cancer
Endocrine OncologyRadioactive iodine (RAI) treatment is an established therapeutic tool for ‘differentiated thyroid cancers’. The therapeutic effectiveness is linked to the preservation of the iodine-concentrating ability of the neoplastic tissue, a unique, inherent ...
Anthony J McGoron +3 more
doaj +3 more sources
Differentiated Thyroid Cancer in Asians [PDF]
Endocrinology and Metabolism, 2016 In the past two decades, thyroid cancer has rapidly increased around the world, including in Korea [1]. Although the exact cause of this increase is still under debate, cancer screening with high-resolution ultrasound (US) might have led to earlier diagnosis of smaller thyroid cancers [2,3,4].
Bo Hyun Kim
doaj +3 more sources
Well-differentiated thyroid cancer [PDF]
Current Problems in Surgery, 1994 Differentiated thyroid cancer (DTC) accounts for 98 % of thyroid cancer, with neoplasms arising from the follicular cells (papillary, follicular and Hurthle cell thyroid cancer) and parafollicular cells (medullary thyroid cancer). This paper will focus on the well-differentiated thyroid cancers arising from the follicular epithelial cells. By retaining
G H, Jossart, O H, Clark
openaire +4 more sources
Progress on Targeted Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
Zhongliu Fangzhi Yanjiu, 2023 Targeted therapy has brought revolutionary breakthroughs for radioiodine-refractory differentiated thyroid cancer. New targeted drugs have prolonged the survival of patients with advanced differentiated thyroid cancer. Multiple tyrosine kinase inhibitors,
TENG Lisong, XU Zehang, WANG Weibin
doaj +1 more source
Radionuclide monitoring of targeted therapy of iodine-negative differentiated thyroid cancer
Український радіологічний та онкологічний журнал, 2021 Background. Current management of treating iodine-negative metastases of differentiated thyroid cancer has its features. In recent years, tyrosine kinase inhibitors (sorafenib, sunitinib) have been registered and indicated to treat refractory forms of ...
О. І. Солодянникова +3 more
doaj +1 more source
Journal of Head & Neck Physicians and Surgeons, 2021 In this chapter, differentiated thyroid cancer (DTC) is discussed focusing on the advanced-stage disease with emphasis on pitfalls in the risk classification, diagnostic workup, follow-up, and treatment.
Dmitrii G. Bel’tsevich +21 more
+5 more sources
Journal of Translational Medicine, 2023 Although the incidence of thyroid cancer is increasing year by year, most patients, especially those with differentiated thyroid cancer, can usually be cured with surgery, radioactive iodine, and thyroid-stimulating hormone suppression.
Sai-li Duan +3 more
doaj +1 more source
Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus. [PDF]
PLoS ONE, 2013 BACKGROUND: Increased body mass index is related to the incidence of thyroid cancer. However, the presentation and therapeutic outcomes of different thyroid cancers and type 2 diabetes mellitus (DM) have not been studied.
Szu-Tah Chen +3 more
doaj +1 more source
Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer [PDF]
Endocrinology and Metabolism, 2017 The incidence of thyroid cancer is growing the fastest among all cancers in the United States, especially in women. The number of patients with thyroid neoplasm is part of an even larger number of patients who often need to undergo an operation to ...
Xuguang Zhu, Sheue-yann Cheng
doaj +1 more source
Frontiers in Oncology, 2022 Hashimoto’s thyroiditis is the most common cause of hypothyroidism in the iodine-sufficient areas of the world. Differentiated thyroid cancer is the most common thyroid cancer subtype, accounting for more than 95% of cases, and it is considered a tumor ...
Federico Cappellacci +6 more
doaj +1 more source